|
|
 | | | |
- close
- close
- close
- close
Sanofi-Aventis SA (SNY) |
QUOTE AND NEWS
FierceBiotech
May 8
Comment
After being accused of bilking her former employer, a court sentenced ex-Sanofi chemist Yuan Li to serve a year and half in prison and pay $131,000 in restitution, Pharmalot reported, citing court documents. Li, a Chinese national who worked for...
FiercePharma
May 8
Comment
Long slated for closure, a Sanofi ($SNY) plant in Missouri is starting to unwind. Layoffs begin June 1 with 112 jobs cut, with more cuts following every 6 months until final shutdown in August 2016. The plant, which once was one of Sanofi's key...
StreetInsider.com
May 8
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Management+Changes/ZIOPHARM+%28ZIOP%29+Taps+Former+Sanofi+%28SNY%29+Exec+Amello+as+CFO/7412042.html for the full story.
The Economic Times
May 3
Comment
Aventis Pharma today said its net profit declined by 20.75 per cent to Rs 40.1 crore for the first quarter ended March 31, 2012, over the same period previous year.
StreetInsider.com
May 3
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Sanofi%27s+%28SNY%29+Genzyme+Gets+EMA%2C+FDA+Approval+for+Second+Suite+at+Irish+Plant/7398097.html for the full story.
PR Newswire
May 2
Comment
BRIDGEWATER, N.J., May 2, 2012 /PRNewswire/ -- Sanofi US announced today that the iBGStar® Blood Glucose Monitoring System, consisting of the iBGStar® blood glucose meter and iBGStar® Diabetes Manager App, is commercially available in the U.S.
PR Newswire
May 1
Comment
SWIFTWATER, Pa., May 1, 2012 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today new Phase III data for its investigational quadrivalent influenza vaccine (QIV) in children 6 months through 8
Market Intelligence Center
May 1
Comment
Sanofi-Aventis (NYSE: SNY) closed Monday's trading session at $38.18. In the past year, the stock has hit a 52-week low of $30.98 and 52-week high of $40.75. Sanofi Aventis (SNY) stock has been showing support around $37.87 and resistance in the...
FiercePharma
Apr 30
Comment
Sanofi ($SNY) had a good first quarter with higher revenues and profits, but executives acknowledge that with Plavix weeks away from coming off patent, the next 12 months will be tough.
The French company reported a net profit of €1.83 billion...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
